Page 152 - Read Online

Balasubramaniam et al. J Transl Genet Genom 2020;4:285-306 I http://dx.doi.org/10.20517/jtgg.2020.34 Page 303

57. Fassone E, Duncan AJ, Taanman JW, Pagnamenta AT, Sadowski MI, et al. FOXRED1, encoding an FAD-dependent oxidoreductase
complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathy. Hum Mol Genet 2010;19:4837-47.
58. Haack TB, Madignier F, Herzer M, Lamantea E, Danhauser K, et al. Mutation screening of 75 candidate genes in 152 complex I
deficiency cases identifies pathogenic variants in 16 genes including NDUFB9. J Med Genet 2012;49:83-9.
59. Zurita Rendón O, Antonicka H, Horvath R, Shoubridge EA. A mutation in the flavin adenine dinucleotide-dependent oxidoreductase
FOXRED1 results in cell-type-specific assembly defects in oxidative phosphorylation complexes I and II. Mol Cell Biol 2016;36:2132-40.
60. Apatean D, Rakic B, Brunel-Guitton C, Hendson G, Bai R, et al. Congenital lactic acidosis, cerebral cysts and pulmonary hypertension in
an infant with FOXRED1 related complex I deficiency. Mol Genet Metab Rep 2019;18:32-8.
61. Formosa LE, Mimaki M, Frazier AE, McKenzie M, Stait TL, et al. Characterization of mitochondrial FOXRED1 in the assembly of
respiratory chain complex I. Hum Mol Genet 2015;24:2952-65.
62. Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007;7 Suppl:S41-50.
63. Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochim Biophys Act.2004;1660:171-99.
64. Acosta Lopez MJ, Trevisson E, Canton M, Vazquez-Fonseca L, Morbidoniet V, et al. Vanillic acid restores coenzyme q biosynthesis and
ATP production in human cells lacking COQ6. Oxid Med Cell Longe 2019;2019:3904905.
65. Heeringa SF, Chernin G, Chaki M, Zhou W, Sloan AJ, et al. COQ6 mutations in human patients produce nephrotic syndrome with
sensorineural deafness. J Clin Invest 2011;121:2013-24.
66. Cao Q, Li GM, Xu H, Shen Q, Sun L, et al. Coenzyme Q (10) treatment for one child with COQ6 gene mutation induced nephrotic
syndrome and literature review. Zhonghua Er Ke Za Zhi 2017;55:135-8. (in Chinese)
67. Gigante M, Diella S, Santangelo L, Trevisson E, Acosta MJ, et al. Further phenotypic heterogeneity of CoQ10 deficiency associated with
steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants. Clin Genet 2017;92:224-6.
68. Park E, Ahn YH, Kang HG, Yoo KH, Won NH, et al. COQ6 mutations in children with steroid-resistant focal segmental
glomerulosclerosis and sensorineural hearing loss. Am J Kidney Di 2017;70:139-44.
69. Li GM, Cao Q, Shen Q, Sun L, Zhai YH, et al. Gene mutation analysis in 12 Chinese children with congenital nephrotic syndrome. BMC
Nephro 2018;19:382.
70. Stanczyk M, Balasz-Chemielewska I, Lipska-Zietkiewicz B, Tkaczyk M. CoQ10-related sustained remission of proteinuria in a child with
COQ6 glomerulopathy-a case report. Pediatr Nephrol 2018;33:2383-7.
71. Yuruk Yildirim Z, Toksoy G, Uyguner O, Nayir A, Yavuz S, et al. Primary coenzyme Q10 Deficiency-6 (COQ10D6): two siblings with
variable expressivity of the renal phenotype. Eur J Med Genet 2020;63:103621.
72. Koyun M, Çomak E, Akman S. CoenzymeQ10 therapy in two sisters with CoQ6 mutations with long-term follow-up. Pediatr Nephrol
2019;34:737-8.
73. Ozeir M, Muhlenhoff U, Webert H, Lill R, Fontecave M, et al. Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation
reaction and substrate analogs rescue Coq6 deficiency. Chem Biol 2011;18:1134-42.
74. Ozaltin F. Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies. Pediatr Nephrol 2014;29:961-9.
75. Herrmann JM, Riemer J. Mitochondrial disulfide relay: redox-regulated protein import into the intermembrane space. J Biol Chem
2012;10:287:4426-33.
76. Bihlmaier K, Mesecke N, Terziyska N, Bien M, Hell K, et al. The disulfide relay system of mitochondria is connected to the respiratory
chain. J Cell Biol 2007;179:389-95.
77. Di Fonzo A, Ronchi D, Lodi T, Fassone E, Tigano M, et al. The mitochondrial disulfide relay system protein GFER is mutated in
autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet 2009;84:594-604.
78. Ceh-Pavia E, Ang SK, Spiller MP, Lu H. The disease-associated mutation of the mitochondrial thiol oxidase Erv1 impairs cofactor
binding during its catalytic reaction. Biochem J 2014;464:449-59.
79. Daithanka VN, Schaefer SA, Dong M, Bahnson BJ, Thorpe C. Structure of the human sulfhydryl oxidase augmenter of liver regeneration
and characterization of a human mutation causing an autosomal recessive myopathy. Biochemistry 2010;49:6737-45.
80. Calderwood L, Holm IA, Teot LA, Anselm I. Adrenal insufficiency in mitochondrial disease: a rare case of GFER-related mitochondrial
encephalomyopathy and review of the literature. J Child Neurol 2016;31:190-4.
81. Nambot S, Gavrilov D, Thevenon J. Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to
data sharing of whole exome sequencing data. Clin Genet 2017;92:188-98.
82. Stehling O, Wilbrecht C, Lill R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 2014;100:61-77.
83. Hanukoglu I, Jefcoate CR. Mitochondrial cytochrome P-450scc. Mechanism of electron transport by adrenodoxin. J Biol Chem
1980;255:3057-61.
84. Paul A, Drecourt A, Petit F. FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial fe-s-synthesis
diseases. Am J Hum Genet 2017;101:630-7.
85. Peng Y, Shinde DN, Valencia AC. Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy.
Human Molecular Genetics 2017;26:4937-50.
86. Slone J, Peng Y, Chamberlin A. Biallelic mutations in FDXR cause neurodegeneration associated with inflammation. J Hum Genet
2018;63:1211-22.
87. Brandt U. Energy converting NADH: quinone oxidoreductase (complex I). Annu Rev Biochem 2006;75:69-92.
88. Scheulke M, Smeitink J, Mariman E, Loeffen J, Plecko B, et al. Mutant NDUFV1 subunit of mitochondrial complex I causes
leukodystrophy and myoclonic epilepsy. Nat Genet 1999;21:260-1.
89. Bénit P, Chretien D, Kadhom N, De-Lonlay-Debeney P, Cormier-Daire V, et al. Large-scale deletion and point mutations of the nuclear